Ascendis Pharma A/S (ASND)
NASDAQ: ASND · Real-Time Price · USD
238.83
+0.17 (0.07%)
May 11, 2026, 11:43 AM EDT - Market open
Ascendis Pharma Market Cap
Ascendis Pharma has a market cap or net worth of $14.83 billion as of May 11, 2026.
Market Cap
14.83B
Enterprise Value
15.20B
1-Year Change
n/a
Ranking
Category
Stock Price
$238.83
Market Cap Chart
Since April 20, 2026, Ascendis Pharma's market cap has decreased from $15.16B to $14.83B, a decrease of -2.15%. That is a compound annual growth rate of -35.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 14.82B | -3.04% |
| May 7, 2026 | 15.29B | 4.90% |
| May 6, 2026 | 14.57B | 4.71% |
| May 5, 2026 | 13.92B | -1.50% |
| May 4, 2026 | 14.13B | 3.52% |
| May 1, 2026 | 13.65B | -3.68% |
| Apr 30, 2026 | 14.17B | 4.13% |
| Apr 29, 2026 | 13.61B | -0.81% |
| Apr 28, 2026 | 13.72B | -2.02% |
| Apr 27, 2026 | 14.00B | -1.14% |
| Apr 24, 2026 | 14.16B | 1.90% |
| Apr 23, 2026 | 13.90B | -2.62% |
| Apr 22, 2026 | 14.27B | -3.85% |
| Apr 21, 2026 | 14.85B | -2.07% |
| Apr 20, 2026 | 15.16B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Roivant Sciences | 20.44B |
| Incyte | 19.69B |
| Genmab | 15.88B |
| Jazz Pharmaceuticals | 14.17B |
| Summit Therapeutics | 14.03B |
| BridgeBio Pharma | 13.20B |
| Ionis Pharmaceuticals | 12.51B |
| Exelixis | 12.11B |